Why Every UK Adult Should Supplement Vitamin D from October to March

The UK's Vitamin D Problem

The United Kingdom sits at a latitude between approximately 50°N and 61°N. This geographic position creates a clinically significant problem: from October to April, the angle at which sunlight strikes the Earth's surface is too oblique for the ultraviolet B (UVB) radiation necessary for skin synthesis of vitamin D to reach the ground in meaningful quantities. For the majority of the year, no amount of time spent outdoors will produce adequate vitamin D in the UK.

This is not a fringe concern. The National Diet and Nutrition Survey (NDNS) consistently finds that a substantial proportion of the UK population has serum 25-hydroxyvitamin D [25(OH)D] levels below 25 nmol/L during winter and spring — the threshold the UK government defines as deficient. Approximately one in five UK adults has low vitamin D status.

What Vitamin D Actually Does

Vitamin D is technically a secosteroid hormone rather than a vitamin in the traditional sense. After synthesis in the skin or absorption from diet or supplements, it is hydroxylated in the liver and then again in the kidneys to its active form, calcitriol. Vitamin D receptors are present in virtually every tissue in the body.

Its best-established roles are in calcium and phosphate regulation (underpinning bone health, with deficiency causing rickets in children and contributing to osteomalacia and osteoporosis in adults), immune modulation, and muscle function. Evidence for vitamin D's role in cardiovascular health, mood regulation, and protection against respiratory infections is growing, though causality is not fully established in all areas.

The NHS Recommendation and Its Limitations

Public Health England recommends 400 IU (10 micrograms) of vitamin D per day for adults during autumn and winter, and year-round for those who are housebound, consistently covered, or from ethnic backgrounds with darker skin pigmentation. This recommendation is principally designed to prevent frank deficiency.

A substantial body of research suggests this recommendation is insufficient to raise serum 25(OH)D to levels associated with optimal health outcomes. Most researchers in the field consider levels above 75 nmol/L to be desirable, and achieving this from the NHS-recommended dose of 400 IU alone is unlikely for most adults, particularly those starting from a deficient baseline.

Clinical trials investigating vitamin D supplementation for outcomes such as immune function, musculoskeletal health, and respiratory infections have typically used doses in the range of 1000–4000 IU. The Endocrine Society in the United States recommends that to reliably raise serum 25(OH)D above 75 nmol/L, adults may require 1500–2000 IU per day under typical circumstances, and up to 6000 IU if obese. A dose of 2000–4000 IU represents a pragmatic middle ground supported by both safety data and evidence for physiological sufficiency.

The tolerable upper limit established by the European Food Safety Authority (EFSA) is 4000 IU per day for adults. This is a conservative figure; toxicity studies show that doses below 10,000 IU daily taken for months rarely cause adverse effects in adults with normal calcium metabolism. Nevertheless, routine supplementation above 4000 IU without testing is not necessary for most people.

The K2 Pairing

There is a well-founded rationale for taking vitamin D3 alongside vitamin K2. Vitamin D significantly increases intestinal calcium absorption. Vitamin K2 (as menaquinone-7, or MK-7) activates matrix Gla protein and osteocalcin, two proteins that direct absorbed calcium into bone rather than allowing it to be deposited in soft tissue. While population evidence for hard cardiovascular outcomes from this combination is not yet definitive, the mechanistic case is sound, and the combination is considered good practice by most integrative practitioners.

Who Is Most at Risk

Certain groups in the UK are at substantially higher risk of vitamin D deficiency regardless of season:

Individuals with darker skin pigmentation require significantly more UVB exposure than those with lighter skin to synthesise equivalent amounts of vitamin D. Melanin acts as a natural sunscreen. UK South Asian, Black African, and Black Caribbean communities are disproportionately affected.

Older adults have reduced skin synthesis capacity — the concentration of 7-dehydrocholesterol, the precursor to vitamin D in the skin, declines significantly with age. Those aged 65 and over synthesise roughly four times less vitamin D from equivalent sun exposure compared to young adults.

People with obesity have lower circulating vitamin D levels for a given intake or exposure, because vitamin D is fat-soluble and partitions into adipose tissue, reducing bioavailability.

Those who cover their skin for religious or cultural reasons, or who are largely confined indoors for health or occupational reasons, have minimal opportunity for sun-derived synthesis.

Breastfed infants are at high risk because breast milk is a poor source of vitamin D; the NHS recommends supplementation from birth.

Testing

A 25(OH)D blood test is the appropriate measure of vitamin D status. NHS testing is available, though clinical access varies. Private testing is widely available and relatively inexpensive. Testing in October before commencing winter supplementation, and again in March, is a sensible approach for individuals managing their own vitamin D. It removes guesswork from dosing decisions and confirms whether a given supplement dose is achieving its intended effect.